Subject
Critical Care and Intensive Care Medicine
Reference6 articles.
1. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation;Fourrier;Chest,1993
2. Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction;Inthorn;Shock,1997
3. Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study;Baudo;Intensive Care Med,1998
4. Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis;Eisele;Intensive Care Med,1998
5. El tratamiento de la sepsis grave y el shock séptico. Aprendiendo de los fracasos;Torrabadella;Med Intensiva,1999